BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9218802)

  • 1. Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappaB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation.
    Watanabe N; Iwamura T; Shinoda T; Fujita T
    EMBO J; 1997 Jun; 16(12):3609-20. PubMed ID: 9218802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-kappa B precursor p100 inhibits nuclear translocation and DNA binding of NF-kappa B/rel-factors.
    Naumann M; Nieters A; Hatada EN; Scheidereit C
    Oncogene; 1993 Aug; 8(8):2275-81. PubMed ID: 8336950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTLV-I encoded Tax in association with NF-kappa B precursor p105 enhances nuclear localization of NF-kappa B p50 and p65 in transfected cells.
    Watanabe M; Muramatsu M; Hirai H; Suzuki T; Fujisawa J; Yoshida M; Arai K; Arai N
    Oncogene; 1993 Nov; 8(11):2949-58. PubMed ID: 8414497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition.
    Franzoso G; Bours V; Park S; Tomita-Yamaguchi M; Kelly K; Siebenlist U
    Nature; 1992 Sep; 359(6393):339-42. PubMed ID: 1406939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activity of a 70 kilodalton I kappa B molecule identical to the carboxyl terminus of the p105 NF-kappa B precursor is modulated by protein kinase A.
    Gerondakis S; Morrice N; Richardson IB; Wettenhall R; Fecondo J; Grumont RJ
    Cell Growth Differ; 1993 Aug; 4(8):617-27. PubMed ID: 8398903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105.
    Belich MP; Salmerón A; Johnston LH; Ley SC
    Nature; 1999 Jan; 397(6717):363-8. PubMed ID: 9950430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells.
    Marienfeld R; Neumann M; Chuvpilo S; Escher C; Kneitz B; Avots A; Schimpl A; Serfling E
    Eur J Immunol; 1997 Jul; 27(7):1601-9. PubMed ID: 9247567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.
    Heissmeyer V; Krappmann D; Wulczyn FG; Scheidereit C
    EMBO J; 1999 Sep; 18(17):4766-78. PubMed ID: 10469655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma.
    Thornburg NJ; Pathmanathan R; Raab-Traub N
    Cancer Res; 2003 Dec; 63(23):8293-301. PubMed ID: 14678988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nuclear I kappaB protein I kappaB zeta specifically binds NF-kappaB p50 homodimers and forms a ternary complex on kappaB DNA.
    Trinh DV; Zhu N; Farhang G; Kim BJ; Huxford T
    J Mol Biol; 2008 May; 379(1):122-35. PubMed ID: 18436238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of nuclear factor-kappa B during primary B cell differentiation.
    Kistler B; Rolink A; Marienfeld R; Neumann M; Wirth T
    J Immunol; 1998 Mar; 160(5):2308-17. PubMed ID: 9498771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-3, a member of the I kappa B proteins, has distinct specificity towards the Rel family of proteins.
    Inoue J; Takahara T; Akizawa T; Hino O
    Oncogene; 1993 Aug; 8(8):2067-73. PubMed ID: 8336935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of p105 processing by NF-kappaB proteins in transiently transfected cells.
    Harhaj EW; Maggirwar SB; Sun SC
    Oncogene; 1996 Jun; 12(11):2385-92. PubMed ID: 8649779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor-kappaB dimer exchange promotes a p21(waf1/cip1) superinduction response in human T leukemic cells.
    Chang PY; Miyamoto S
    Mol Cancer Res; 2006 Feb; 4(2):101-12. PubMed ID: 16513841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis.
    Budunova IV; Perez P; Vaden VR; Spiegelman VS; Slaga TJ; Jorcano JL
    Oncogene; 1999 Dec; 18(52):7423-31. PubMed ID: 10602501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice.
    Ryu H; Smith K; Camelo SI; Carreras I; Lee J; Iglesias AH; Dangond F; Cormier KA; Cudkowicz ME; Brown RH; Ferrante RJ
    J Neurochem; 2005 Jun; 93(5):1087-98. PubMed ID: 15934930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide from Salmonella enterica activates NF-kappaB through both classical and alternative pathways in primary B Lymphocytes.
    Souvannavong V; Saidji N; Chaby R
    Infect Immun; 2007 Oct; 75(10):4998-5003. PubMed ID: 17698569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
    Cogswell PC; Guttridge DC; Funkhouser WK; Baldwin AS
    Oncogene; 2000 Feb; 19(9):1123-31. PubMed ID: 10713699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytosol is the prime compartment of hepatitis B virus X protein where it colocalizes with the proteasome.
    Sirma H; Weil R; Rosmorduc O; Urban S; Israël A; Kremsdorf D; Bréchot C
    Oncogene; 1998 Apr; 16(16):2051-63. PubMed ID: 9572486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes.
    Hsing Y; Hostager BS; Bishop GA
    J Immunol; 1997 Nov; 159(10):4898-906. PubMed ID: 9366415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.